News & Videos - INVACARE CORP.

Invacare Corporation (NYSE: IVC) (“Invacare” or “the company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced actions to strengthen the company and position it for long-term success. To facilitate its financial restructuring, the company has entered into a Restructuring Support Agreement (the “RSA” or “Agreement”) with substantially all of its debt holders, including its term loan lender, all of the holders of...

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announced the consummation of an additional draw of $5,500,000 of term loans under to its Credit Agreement with certain funds managed by Highbridge Capital Management LLC (“Highbridge”), as of December 23, 2022. Commenting on the financing, Geoff Purtill, president and chief executive officer stated, “As guided in the 3Q22 earnings release, Europe achieved sequential growth in revenues and profitability driven by...

Invacare Corporation (NYSE: IVC) announced today that its Board of Directors has named Geoffrey P. Purtill as President and Chief Executive Officer, roles that he has served on an interim basis since August 28, 2022. Non-executive Chairman of the Board of Directors Michael J. Merriman, Jr, said, “On behalf of the Board, we are excited to elevate Geoff Purtill into the role of President and CEO. The Board determined that Geoff is the right steward of the company as it undergoes significant...

Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended September 30, 2022. Executive Summary Reflecting on the quarter and the company's progress against its transformation program, Geoffrey Purtill, interim president and chief executive officer, said "We remain committed to taking necessary and decisive action to increase shareholder value. After carefully evaluating our strategic options, we have determined that the lifestyle and mobility &...

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Monday, November 7, 2022. The company will provide a live conference call and webcast to discuss these financial results on Tuesday, November 8, 2022, at 8:30 AM ET. Investors and other interested parties may access the webcast and conference call in the following ways: Those wishing to participate...

Invacare Corporation (NYSE: IVC) today announced that it received notice from the New York Stock Exchange (the “NYSE”) that the company is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the company’s Common Shares was less than $1.00 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company’s Common Shares from the NYSE. The company plans to notify the NYSE by...

Invacare Corporation (NYSE: IVC) today announced that it has entered into a cooperation agreement with its largest shareholder, Azurite Management LLC (“Azurite”), which currently owns approximately 10.3% of the company’s outstanding shares as of June 30, 2022. As part of the agreement, Invacare appointed two new independent directors, Steven H. Rosen and Ambassador Edward F. Crawford, effective immediately. Mr. Rosen will serve on the company’s Audit and Compensation and Management...

Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended June 30, 2022. Executive Summary Reflecting on the quarter, Matt Monaghan, chairman, president, and chief executive officer, said "In 2Q22, we achieved sequential revenue growth of 4.7% in mobility & seating products driven by increased adoption of our compelling product portfolio. We continue to experience elevated backlog across all product categories and regions, and see strong demand...

Invacare Corporation (“Invacare”) (NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, has been recognized by Mobility Management magazine in multiple product categories for outstanding product and technology development in complex rehab. “We are pleased to once again be recognized for our industry-leading mobility products which deliver important user benefits. These awards are a testament to our culture of innovation and reflect our...

Invacare Corporation (NYSE:IVC) (“Invacare” or the “company”) announced today that it completed a series of strategic capital market transactions that will enable the company to address its elevated backlog level, increase its overall financial flexibility, and better position the company to achieve its growth and profitability goals. New Strategic Financing Secured The company entered into a senior secured Term Loan Agreement with certain funds managed by Highbridge Capital Management...

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the second quarter ended June 30, 2022, after the market closes on Monday, August 8, 2022. The company will provide a live conference call and webcast to discuss these financial results on Tuesday, August 9, 2022, at 8:30 AM ET. Investors and other interested parties may access the webcast and conference call in the following ways: Those wishing to participate via...

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will participate in the 22 nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022. The company’s management team will be available for 1x1 meetings with interested investors. About Invacare Corporation Invacare Corporation is a leading...

Invacare Corporation (NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced that Matt Monaghan, chairman, president and chief executive officer, will present at the 12 th Annual East Coast IDEAS Investor Conference on Wednesday, June 22, 2022. The webcast of the presentation will be available at https://wsw.com/webcast/threepa37/ivc/ and it will be accessible for replay for 90 days following the conference. The company’s...

Invacare Corporation (NYSE: IVC) announced the U.S. introduction of its Birdie™ Evo XPLUS, an innovative patient lift solution for the post-acute care setting. With its sleek and modern design, the Birdie Evo XPLUS provides innovative technology that helps maximize comfort and security when lifting or transferring a patient to or from a bed, chair or floor. Incorporating the most valued features paired with the new technology, customers and end-users will appreciate the unique and enhanced...

Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended March 31, 2022. Executive Summary Reflecting on the quarter, Matt Monaghan, chairman, president, and chief executive officer, said "In 1Q22, we delivered 2.4% reported net sales and 6.4% constant currency net sales growth driven by sales of mobility & seating products which achieved double-digit growth. We are pleased that strong demand continued across our entire portfolio of products. As...

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the first quarter ended March 31, 2022, after the market closes on Monday, May 9, 2022. The company will provide a live conference call and webcast to discuss these financial results on Tuesday, May 10, 2022, at 8:30 AM ET. Investors and other interested parties may access the webcast and conference call in the following ways: Those wishing to participate via webcast...

Invacare Corporation (NYSE: IVC) today announced the appointment of Aron I. Schwartz, age 51, to its Board of Directors, effective March 21, 2022. Mr. Schwartz currently serves as Managing Partner of ACON Investments, a private equity firm based in Washington, D.C. Mr. Schwartz has a wide range of financial experience in managing and overseeing companies across multiple industries, including companies undergoing strategic transformation. Mr. Schwartz was unanimously appointed by the current...

Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today announced its financial results for the fourth quarter and year ended December 31, 2021. Executive Summary Reflecting on 2021 results, Matt Monaghan, chairman, president and chief executive officer, commented, "We ended the year sustaining strong new order intake and growing customer interest in our leading portfolio of products. We continue to manage this demand and to take actions to mitigate against higher input costs and...

Invacare Corporation (NYSE: IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, announces its conference schedule for March 2022: Tuesday, March 15, the Company will participate in the 32 nd Annual Oppenheimer Healthcare Conference. Tuesday, March 22, the Company will participate in the KeyBanc Life Sciences & MedTech Investor Forum. The company’s management team, including Matt Monaghan, chairman, president and chief executive officer; Kathy...

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the fourth quarter and year ended December 31, 2021, after the market closes on Tuesday, March 8, 2022. The company will provide a live conference call and webcast to discuss these financial results on Wednesday, March 9, 2022 at 8:30 AM ET. Investors and other interested parties may access the webcast and conference call in the following ways: Those wishing to...